TG Therapeutics (TGTX) Misses Q2 EPS by 8c

August 10, 2015 9:14 AM

TG Therapeutics (NASDAQ: TGTX) reported Q2 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.